| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4a14c1480e0de1e44258c99ac967ba0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c37762188a56acca3ecbc14acf8881b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc3aca389e1b1e2b0af31c451da420cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a74a120402fd2c7f31df225958cfde8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2858411320fb0a2e0a846742666185f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b602deeaa8927253e334193971e0d445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f01d7796555bb36ac9f9cef0c89d388 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2011-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cb8f08f7b402e6abca6d71e998f1c88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7a54aba2d065f9c50be1aea603b3f5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35a3a2a4aff3e4cbe437bed0fe2ea9fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8d03031ee4df8242b7720dcfe88ebda |
| publicationDate |
2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012126542-A2 |
| titleOfInvention |
Biomarkers and methods for the prognosis of glioblastoma |
| abstract |
The present invention relates to gene promoters whose methylation status correlates with the clinical survival outcome of glioblastoma patients treated according to the Stupp protocol. More specifically, the invention provides methods and kits for the prognosis of survival outcome and/or treatment response in glioblastoma patients. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115747329-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115747329-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109021100-A |
| priorityDate |
2011-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |